Medical Devices & Equipment
98 companies across the library’s three pools, one row each. The columns are the line items this kind of business is read on; each header names its basis, and the margins and returns are medians over each company’s readable record — the through-cycle level, never one year’s print. Rows open largest first by latest-year revenue, and every column sorts both ways — the re-ordering is the reader’s own act, and a sorted view keeps its order in the address bar. The company stays in view as the columns scroll. A dash is a figure that could not be read; n/a is one that does not apply to that member; both sit at the back of a sorted column.
From the latest filings · data as of July 9, 2026.
As a group: median revenue $756M; median gross margin 63.9%; median operating margin 3.6%; median owner earnings $46M; median return on invested capital 4.0%; 43 of 94 hold net cash. Medians of this table’s own columns, over the members each applies to · data as of July 9, 2026.
Pick two to four to weigh side by side. Compare these →
| latest fiscal year, USD | median over the record | median over the record | op. cash − maintenance capex · latest FY, USD | after tax · median over the record | debt − cash & ST investments · latest FY, USD | ||||
|---|---|---|---|---|---|---|---|---|---|
| MDT | Medtronic plc. | Medical Devices & Equipment | $36.4B | 65.7% | 17.8% | $5.4B | 6.0% | $17.0B | |
| MDLN | Medline Inc. | Medical Devices & Equipment | $28.4B | 26.4% | 7.8% | $1.3B | — | $10.6B | |
| SYK | Stryker Corporation | Medical Devices & Equipment | $25.1B | 64.0% | 18.2% | $4.3B | 10.3% | $11.8B | |
| MMM | 3M Company | Medical Devices & Equipment | $24.9B | 46.7% | 19.6% | $1.4B | 21.8% | $7.0B | |
| BDX | Becton Dickinson and Company | Medical Devices & Equipment | $21.8B | 45.2% | 11.5% | $2.7B | 4.8% | $18.5B | |
| GEHC | GE Healthcare Technologies Inc. | Medical Devices & Equipment | $20.6B | — | 13.4% | $1.5B | 13.4% | $5.5B | |
| BSX | Boston Scientific Corporation | Medical Devices & Equipment | $20.1B | 69.0% | 14.1% | $3.7B | 5.2% | $9.2B | |
| BAX | Baxter International Inc. | Medical Devices & Equipment | $11.2B | 39.3% | 7.3% | $332M | 5.3% | $2.4B | |
| ALC | Alcon Inc. | Medical Devices & Equipment | $10.4B | 55.1% | 7.0% | $2.1B | 2.1% | $2.7B | |
| ISRG | Intuitive Surgical Inc. | Medical Devices & Equipment | $10.1B | 67.5% | 29.3% | $2.5B | 15.5% | +$5.9B cash | |
| SOLV | Solventum Corporation | Medical Devices & Equipment | $8.3B | — | 20.6% | ($10M) | 11.5% | $4.2B | |
| ZBH | Zimmer Biomet Holdings Inc. | Medical Devices & Equipment | $8.2B | 71.3% | 10.7% | $1.5B | 3.7% | $6.9B | |
| 4543 | Terumo | Medical Devices & Equipment | $7.0B | 53.2% | 15.6% | $897M | 8.5% | $612M | |
| 7733 | Olympus | Medical Devices & Equipment | $6.2B | 63.9% | 10.3% | $277M | 12.2% | $317M | |
| SNN | Smith & Nephew SNATS Inc. | Medical Devices & Equipment | $6.2B | 70.4% | 11.4% | $852M | 11.2% | $827M | |
| EW | Edwards Lifesciences Corporation | Medical Devices & Equipment | $6.1B | 75.4% | 25.3% | $1.4B | 20.2% | +$3.6B cash | |
| STE | Steris | Medical Devices & Equipment | $5.9B | 43.2% | 15.9% | $972M | 7.9% | $1.5B | |
| 7741 | Hoya | Medical Devices & Equipment | $5.8B | 82.3% | n/a | $1.4B | n/a | — | |
| RMD | ResMed Inc. | Medical Devices & Equipment | $5.1B | 57.3% | 26.8% | $1.7B | 16.1% | +$541M cash | |
| BLCO | Bausch + Lomb Corporation | Medical Devices & Equipment | $5.1B | — | 3.4% | ($66M) | 1.1% | $4.7B | |
| DXCM | DexCom Inc. | Medical Devices & Equipment | $4.7B | 64.4% | 10.9% | $1.2B | 9.2% | $231M | |
| HOLX | Hologic | Medical Devices & Equipment | $4.1B | 61.6% | 19.4% | $998M | 10.6% | $316M | |
| COO | The Cooper Companies Inc. | Medical Devices & Equipment | $4.1B | 64.7% | 16.5% | $434M | 4.5% | $2.4B | |
| ALGN | Align Technology | Medical Devices & Equipment | $4.0B | 71.3% | 17.2% | $491M | 17.0% | +$1.4B cash | |
| XRAY | DENTSPLY SIRONA Inc. | Medical Devices & Equipment | $3.7B | 52.6% | -11.5% | $104M | -10.2% | $1.9B | |
| MMED | MiniMed Group Inc. | Medical Devices & Equipment | $3.1B | 56.3% | -5.4% | ($353M) | -3.5% | +$298M cash | |
| WST | West Pharmaceutical | Medical Devices & Equipment | $3.1B | 34.5% | 19.0% | $583M | 18.1% | +$596M cash | |
| GMED | Globus Medical | Medical Devices & Equipment | $2.9B | 74.2% | 17.9% | $589M | 10.5% | +$140M cash | |
| NVST | Envista Holdings | Medical Devices & Equipment | $2.7B | 56.3% | 10.3% | $230M | 4.1% | $237M | |
| PODD | Insulet Corporation | Medical Devices & Equipment | $2.7B | 65.1% | 5.7% | $479M | 4.8% | $502M | |
| ENOV | Enovis Corporation | Medical Devices & Equipment | $2.2B | 54.5% | -4.4% | $20M | -1.0% | $1.3B | |
| ICUI | ICU Medical | Medical Devices & Equipment | $2.2B | 36.3% | 1.9% | $92M | 3.0% | $962M | |
| TFX | Teleflex | Medical Devices & Equipment | $2.0B | 54.6% | 16.5% | $1M | 7.3% | $2.3B | |
| MSA | MSA Safety Incorporated | Medical Devices & Equipment | $1.9B | 45.1% | 12.9% | $295M | 13.0% | $416M | |
| ITGR | Integer Holdings | Medical Devices & Equipment | $1.9B | 27.0% | 11.1% | $105M | 5.8% | $1.2B | |
| IART | Integra Lifesciences Holdings Corp | Medical Devices & Equipment | $1.6B | 61.2% | 7.2% | $6M | 4.4% | $1.5B | |
| MASI | Masimo | Medical Devices & Equipment | $1.5B | 65.0% | 20.3% | $198M | 30.2% | $372M | |
| MMSI | Merit Medical Systems | Medical Devices & Equipment | $1.5B | 44.8% | 5.8% | $216M | 3.9% | $299M | |
| PEN | Penumbra | Medical Devices & Equipment | $1.4B | 64.5% | 0.3% | $221M | 0.3% | +$382M cash | |
| LIVN | LivaNova PLC | Medical Devices & Equipment | $1.4B | 66.8% | -5.9% | $226M | -4.0% | +$259M cash | |
| CNMD | CONMED | Medical Devices & Equipment | $1.4B | 54.6% | 7.5% | $151M | 5.0% | $794M | |
| HAE | Haemonetics | Medical Devices & Equipment | $1.3B | 49.0% | 10.3% | $260M | 7.2% | $979M | |
| OMCL | Omnicell | Medical Devices & Equipment | $1.2B | 45.4% | 1.6% | $87M | 1.5% | +$29M cash | |
| TNDM | Tandem Diabetes Care | Medical Devices & Equipment | $1.0B | 51.5% | -18.5% | ($30M) | -34.1% | $58M | |
| INSP | Inspire Medical Systems | Medical Devices & Equipment | $912M | 83.8% | -40.3% | $103M | -19.5% | +$284M cash | |
| WRBY | Warby Parker Inc. | Medical Devices & Equipment | $872M | 57.0% | -10.7% | $61M | -67.0% | +$286M cash | |
| OFIX | Orthofix Medical Inc. Common Stock (DE) | Medical Devices & Equipment | $822M | 74.9% | -2.9% | ($1M) | -3.7% | $75M | |
| ATEC | Alphatec Holdings | Medical Devices & Equipment | $764M | 67.1% | -36.0% | $3M | -47.4% | $405M | |
| IRTC | iRhythm Technologies | Medical Devices & Equipment | $747M | 68.9% | -25.5% | $60M | -28.9% | $66M | |
| AVNS | Avanos Medical Inc. | Medical Devices & Equipment | $701M | 55.1% | -7.0% | $43M | -2.9% | $158M | |
| NVCR | NovoCure | Medical Devices & Equipment | $655M | 74.8% | -22.2% | ($64M) | -23.5% | $101M | |
| CDRE | Cadre Holdings Inc. | Medical Devices & Equipment | $610M | 39.9% | 11.7% | $57M | 10.9% | $184M | |
| TMDX | TransMedics Group | Medical Devices & Equipment | $605M | 62.3% | -93.0% | $166M | -18.3% | +$103M cash | |
| UFPT | UFP Technologies Inc. | Medical Devices & Equipment | $603M | 25.4% | 10.3% | $82M | 10.6% | $115M | |
| BVS | Bioventus Inc. | Medical Devices & Equipment | $568M | 68.3% | 2.8% | $72M | -2.7% | $243M | |
| ATRC | AtriCure | Medical Devices & Equipment | $535M | 75.2% | -12.9% | $48M | -7.9% | +$99M cash | |
| GKOS | Glaukos Corporation | Medical Devices & Equipment | $507M | 76.0% | -29.1% | ($22M) | -9.4% | $192M | |
| AORT | Artivion Inc. | Medical Devices & Equipment | $441M | 65.8% | 3.5% | $17M | 3.6% | $150M | |
| MDXG | MiMedx Group Inc | Medical Devices & Equipment | $419M | 83.6% | -1.1% | $73M | 33.8% | +$148M cash | |
| INMD | InMode Ltd. | Medical Devices & Equipment | $370M | 83.8% | 35.3% | $85M | 34.7% | +$386M cash | |
| TCMD | Tactile Systems Technology Inc. | Medical Devices & Equipment | $330M | 71.2% | 3.6% | $40M | 8.0% | +$60M cash | |
| ANGO | AngioDynamics Inc. | Medical Devices & Equipment | $320M | 53.9% | -12.5% | $508K | -10.5% | +$68M cash | |
| PRCT | PROCEPT BioRobotics Corporation | Medical Devices & Equipment | $308M | 49.4% | -107.6% | ($55M) | -115.2% | +$235M cash | |
| LMAT | LeMaitre Vascular Inc. | Medical Devices & Equipment | $250M | 68.1% | 20.9% | $74M | 11.9% | $140M | |
| STAA | STAAR Surgical Company | Medical Devices & Equipment | $239M | 74.5% | 5.3% | ($40M) | 8.8% | +$183M cash | |
| KIDS | OrthoPediatrics Corp. | Medical Devices & Equipment | $236M | 74.2% | -17.1% | ($16M) | -7.2% | $41M | |
| CERS | Cerus Corporation | Medical Devices & Equipment | $234M | 58.4% | -51.1% | $3M | -43.1% | $35M | |
| AXGN | Axogen Inc. | Medical Devices & Equipment | $225M | 80.8% | -20.0% | ($3M) | -17.2% | $9M | |
| ESTA | Establishment Labs Holdings Inc. | Medical Devices & Equipment | $211M | 64.8% | -33.0% | ($57M) | -40.3% | $172M | |
| SIBN | SI-BONE Inc. | Medical Devices & Equipment | $201M | 87.9% | -36.2% | ($6M) | -21.5% | +$7M cash | |
| HTFL | Heartflow Inc. | Medical Devices & Equipment | $176M | 75.1% | -48.7% | ($59M) | — | +$177M cash | |
| BBNX | Beta Bionics Inc. | Medical Devices & Equipment | $100M | 55.1% | -71.5% | ($52M) | — | +$219M cash | |
| NPCE | Neuropace Inc. | Medical Devices & Equipment | $100M | 73.6% | -41.5% | ($11M) | -31.6% | +$2M cash | |
| BFLY | Butterfly Network Inc. | Medical Devices & Equipment | $98M | 27.3% | -263.0% | ($16M) | -134.4% | +$226M cash | |
| BLFS | BioLife Solutions Inc. | Medical Devices & Equipment | $96M | 64.6% | -9.6% | $18M | -3.8% | +$28M cash | |
| KMTS | Kestra Medical Technologies Ltd. | Medical Devices & Equipment | $95M | 40.5% | -177.8% | ($90M) | — | +$154M cash | |
| CBLL | CeriBell Inc. | Medical Devices & Equipment | $89M | 86.7% | -65.6% | ($42M) | — | +$139M cash | |
| DCTH | Delcath Systems Inc. | Medical Devices & Equipment | $85M | 81.1% | -690.0% | $22M | -227.1% | +$38M cash | |
| IRMD | iRadimed Corporation | Medical Devices & Equipment | $84M | 76.6% | 23.5% | $24M | 50.3% | +$59M cash | |
| FOCL | EDAP TMS S.A. | Medical Devices & Equipment | $71M | — | — | ($18M) | — | +$2M cash | |
| ELMD | Electromed Inc. | Medical Devices & Equipment | $64M | 76.4% | 9.6% | $11M | 10.8% | +$14M cash | |
| APT | Alpha Pro Tech Ltd. | Medical Devices & Equipment | $59M | 38.0% | 6.7% | $2M | 9.3% | +$17M cash | |
| SI | Shoulder Innovations Inc. | Medical Devices & Equipment | $47M | — | — | ($32M) | — | +$12M cash | |
| BWAY | BrainsWay Ltd. | Medical Devices & Equipment | $46M | 76.7% | -31.2% | $22M | -142.7% | +$66M cash | |
| SSII | SS Innovations International Inc. | Medical Devices & Equipment | $42M | 12.3% | -206.0% | ($20M) | -85.6% | +$2M cash | |
| CLPT | ClearPoint Neuro Inc. | Medical Devices & Equipment | $37M | 61.4% | -79.5% | ($24M) | -234.0% | $3M | |
| BDMD | Baird Medical Investment Holdings Ltd | Medical Devices & Equipment | $23M | 83.8% | 37.7% | ($1M) | 26.8% | $9M | |
| DRIO | DarioHealth Corp. | Medical Devices & Equipment | $22M | 29.4% | -276.1% | ($26M) | -89.0% | $14M | |
| PROF | Profound Medical Corp. | Medical Devices & Equipment | $16M | 62.6% | -339.4% | ($38M) | -256.8% | +$53M cash | |
| CV | CapsoVision Inc. | Medical Devices & Equipment | $14M | — | — | ($23M) | — | — | |
| NNOX | NANO-X IMAGING LTD | Medical Devices & Equipment | $13M | — | -631.9% | ($41M) | -51.2% | +$61M cash | |
| NSPR | InspireMD Inc. | Medical Devices & Equipment | $9M | 21.2% | -361.9% | ($37M) | -84.7% | +$49M cash | |
| AVR | Anteris Technologies Global Corp. | Medical Devices & Equipment | $2M | — | — | ($80M) | — | +$13M cash | |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | Medical Devices & Equipment | $350K | — | -8293.9% | ($54M) | -703.5% | +$89M cash | |
| QTEX | QTREX Quantum Ltd. | Medical Devices & Equipment | $289K | — | — | ($10M) | — | +$3M cash | |
| MBOT | Microbot Medical Inc. | Medical Devices & Equipment | $117K | 73.7% | -2300.1% | ($13M) | — | +$78M cash | |
| PHG | KONINKLIJKE PHILIPS NV | Medical Devices & Equipment | as filed: €17.8B | 45.2% | 7.3% | as filed: €903M | 6.9% | as filed: €4.2B | |
| STVN | Stevanato Group S.p.A. | Medical Devices & Equipment | as filed: €1.2B | 29.3% | 16.8% | as filed: €208M | 19.1% | as filed: (€141M) |
Every figure is recomputed from the company’s own SEC or EDINET filings, the same way as on its page; the columns name facts, weigh nothing, and form no rank. Foreign filers are stated in US dollars at the dated reference rate (as of 2026-07-17) so each money column sorts on one basis; their own pages keep the records as filed. A foreign filer whose conversion terms are missing shows its money as filed and sorts to the back of the column — never a guessed conversion. Ratios and margins are currency-free.